FRI-058-YI Time-resolved liver fibrosis regression at single-cell resolution in a murine CCl4-cessation model
Katharina Bonitz(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Eric J. Simon(Boehringer Ingelheim (Germany)), Philipp Schwabl(Austrian Academy of Sciences), Hubert Scharnagl(Medical University of Graz), Oleksandr Petrenko(Austrian Academy of Sciences), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Peng Sun(Peking University), Henriette Horstmeier, Thomas Sorz‐Nechay(Austrian Academy of Sciences), Stefan Günther Kauschke, Kerstin Zinober(Medical University of Vienna), Benedikt Simbrunner(Medical University of Vienna)
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399